Email updates

Keep up to date with the latest news and content from Genome Biology and BioMed Central.

Highly Accessed Protein family review

Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs

Anne M Verhagen*, Elizabeth J Coulson and David L Vaux

Author Affiliations

The Walter and Eliza Hall Institute of Medical Research, Post Office, Royal Melbourne Hospital, Victoria 3050, Australia

For all author emails, please log on.

Genome Biology 2001, 2:reviews3009-reviews3009.10  doi:10.1186/gb-2001-2-7-reviews3009

Published: 5 July 2001

Abstract

Apoptosis is a physiological cell death process important for development, homeostasis and the immune defence of multicellular animals. The key effectors of apoptosis are caspases, cysteine proteases that cleave after aspartate residues. The inhibitor of apoptosis (IAP) family of proteins prevent cell death by binding to and inhibiting active caspases and are negatively regulated by IAP-binding proteins, such as the mammalian protein DIABLO/Smac. IAPs are characterized by the presence of one to three domains known as baculoviral IAP repeat (BIR) domains and many also have a RING-finger domain at their carboxyl terminus. More recently, a second group of BIR-domain-containing proteins (BIRPs) have been identified that includes the mammalian proteins Bruce and Survivin as well as BIR-containing proteins in yeasts and Caenorhabditis elegans. These Survivin-like BIRPs regulate cytokinesis and mitotic spindle formation. In this review, we describe the IAPs and other BIRPs, their evolutionary relationships and their subcellular and tissue localizations.